Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03985371 · ClinicalTrials.gov registry record · Early Phase 1
A Pilot Study to Assess the Preliminary Efficacy of EDTA Eye Drops on Band Keratopathy
A Early Phase 1 study of Corneal Dystrophy, Band-Shaped, sponsored by University of Rochester.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT03985371: Completed Early Phase 1 study of Corneal Dystrophy, Band-Shaped, sponsored by University of Rochester.
NCT03985371 is a Early Phase 1 study of Corneal Dystrophy, Band-Shaped that has completed, run by University of Rochester. The registered enrollment target is 3 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03985371, a Early Phase 1 study of Corneal Dystrophy, Band-Shaped, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to collect preliminary efficacy and safety data on the use of EDTA EYE Drops (EED) on subjects during an episode of band keratopathy (BK).
Primary Outcome
Photographs will be full, direct views taken with a Zeiss model 450 plus split lamp camera.
Conditions Studied
Interventions
- DRUG EDTA Eye Drops
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2020-06-29 |
| Est. Completion | 2021-09-30 |
| Phase | Early Phase 1 |
What the finished NCT03985371 record still lists
NCT03985371 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Corneal Dystrophy, Band-Shaped appearing as the primary indexed condition, and to 1 intervention - of which EDTA Eye Drops is the first listed.
NCT03985371 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03985371 about?
NCT03985371 is a clinical study titled "A Pilot Study to Assess the Preliminary Efficacy of EDTA Eye Drops on Band Keratopathy". The objective of this study is to collect preliminary efficacy and safety data on the use of EDTA EYE Drops (EED) on subjects during an episode of band keratopathy (BK).
What is the current status of trial NCT03985371?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2020-06-29. Estimated completion is 2021-09-30.
What conditions does trial NCT03985371 study?
This clinical trial studies the following conditions: Corneal Dystrophy, Band-Shaped.
What interventions are being tested in trial NCT03985371?
The interventions under investigation include: EDTA Eye Drops (DRUG).
Who is sponsoring clinical trial NCT03985371?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03985371 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03985371's enrollment target sits among peer trials
3 1949th of 2000 higher than 28 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI